cephalosporin c has been researched along with cefditoren in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (9.57) | 18.2507 |
2000's | 72 (62.61) | 29.6817 |
2010's | 23 (20.00) | 24.3611 |
2020's | 9 (7.83) | 2.80 |
Authors | Studies |
---|---|
Bhogal, H; Clark, S; Dencer, CA; Felmingham, D; Ghosh, G; Grüneberg, RN; Leakey, A; Mehta, MD; Ridgway, GL; Robbins, MJ | 1 |
Coronel, P; Fernández-Roblas, R; Gimeno, M; López, JC; Ramos, JM; Soriano, F | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
Coronel, P; Fernández-Roblas, R; García-Corbeira, P; Gimeno, M; Jiménez, M; Soriano, F | 1 |
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
Barrett, MS; Biedenbach, DJ; Croco, MA; Jones, RN | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Appelbaum, PC; Jacobs, MR; Kelly, LM | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Hanaki, H; Hiramatsu, K; Inaba, Y | 1 |
Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Nishiyama, T; Saika, T | 1 |
Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA | 1 |
Biedenbach, DJ; Johnson, DM; Jones, RN | 1 |
Dubois, J; St-Pierre, C | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Hijioka, S; Inoue, S; Kugo, Y; Nishimura, T; Oguni, T; Sugiki, M; Sugita, K; Uemura, T; Wakamiya, E; Yoshikawa, K | 1 |
Platt, D; Rieck, W | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Barry, AL; Brown, SD; Fuchs, PC; Traczewski, MM | 1 |
Al-Lahham, A; Lütticken, R; Reinert, RR | 1 |
Thompson, CA | 1 |
Guay, DR | 1 |
Critchley, IA; Draghi, DC; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C | 2 |
Appelbaum, PC; Clark, CL; Dewasse, BE; Ednie, LM; Jacobs, MR; Nagai, K; Pankuch, GA | 1 |
Bucko, AD; Hom, R; Hunt, BJ; Kidd, SL | 1 |
Balbisi, EA | 1 |
Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Kataoka, S | 1 |
Uno, Y | 1 |
Furukawa, M; Ito, M | 1 |
Iwata, T; Tajima, T | 1 |
Yokoyama, M | 1 |
Ubukata, K | 1 |
Sakata, H | 2 |
Suzuki, K | 1 |
Ogata, H | 1 |
Shibata, M | 1 |
Ito, M | 1 |
Ichimaru, T | 1 |
Hajdú, E; Marton, A; Nagy, E | 1 |
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
Cartier, LL; Cheung, BW; Giebink, GS; Sawchuk, RJ; Zhu, T | 1 |
Kaye, KM; Martin, SI | 1 |
Cao, LD; Naruhiko, I; Nobue, T; Yoichi, K | 1 |
Chimura, T; Murayama, K | 1 |
Kandikere, VN; Mudigonda, K; Nirogi, RV; Shrivastava, W | 1 |
Baek, JY; Ko, KS; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Song, JH; Suh, JY | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Aguilar, L; Casal, J; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Robledo, O | 1 |
Aguilar, L; Alou, L; Cafini, F; Echeverría, O; Giménez, MJ; Gómez-Lus, ML; González, N; Sevillano, D; Torrico, M | 1 |
Aguilar, L; Coronel, P; Galarza, P; Giménez, MJ; Martín, E; Vázquez, JA | 1 |
Hikida, M; Maebashi, K; Mikuniya, T; Niida, M; Shimizu, A; Ubukata, K | 1 |
Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 2 |
Bulitta, J; Drusano, GL; Hinder, M; Kinzig-Schippers, M; Lodise, TP; Loos, U; Sörgel, F; Vogel, F | 1 |
Azanza, JR; Campanero, MA; Coronel, P; Gimeno, M; Honorato, J; Quetglas, EG; Sádaba, B | 1 |
Aguilar, L; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
Aguilar, L; Alou, L; Echeverria, O; Gomez-Lus, ML; Gonzalez, N; Prieto, J; Sevillano, D | 1 |
Jung, DS; Ko, KS; Kwon, KT; Lee, MY; Lee, NY; Peck, KR; Song, JH; Suh, JY | 1 |
Baba, N; Miyara, T; Ohsawa, F; Saito, J; Takeuchi, Y; Watanabe, T; Yamada, M | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Relaño, MT; Sevillano, D; Torrico, M | 1 |
Aguilar, L; Coronel, P; Gimenez, MJ; Granizo, JJ; Honorato, J; Sádaba, B; Sevillano, D | 1 |
Coronel, P; del Prado, G; Díaz, C; García-Rodas, R; Gimeno, M; Gracia, M; Granizo, JJ; Huelves, L; Naves, PL; Ponte, MC; Ruiz, V; Soriano, F | 1 |
Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
Biedenbach, DJ; Fritsche, TR; Jones, RN | 2 |
Aguilar, L; Barberán, J; Coronel, P; Giménez, MJ; Gimeno, M; Granizo, JJ | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Fenoll, A; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Becerril, R; Castillo, FJ; Coronel, P; Durán, E; Gimeno, M; Gómez-Lus, R; Oca, M; Rubio-Calvo, C; Seral, C; Suárez, L | 1 |
Fadda, G; Mattina, R; Mezzatesta, ML; Nicoletti, G; Palù, G; Rossano, F; Schito, GC; Stefani, S; Tufano, MA | 1 |
Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 2 |
Biedenbach, DJ; Jones, RN | 1 |
Liu, K; Liu, Q; Ma, X; Peng, J; Wang, C; Wu, J; Zhang, Q | 1 |
Aguilar, L; Coronel, P; Gimenez, MJ; Gimeno, M; Granizo, JJ; Prieto, J | 1 |
Gona, F; Marchese, G; Mezzatesta, ML; Nicoletti, G; Nicolosi, D; Stefani, S; Toscano, MA | 1 |
Barberán, J; Mensa, J | 1 |
Bouza, E; Cercenado, E; Coronel, P; Cuevas, O; Gimeno, M; Marín, M | 1 |
Carlone, NA; Cocuzza, C; Furneri, PM; Musumeci, R; Nicoletti, G; Pilloni, AP; Prenna, M; Rigoli, R; Tempera, G; Tufano, MA; Tullio, V; Vitali, LA | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; García, E; Giménez, MJ; González, N; Prieto, J; Ramos-Sevillano, E; Sevillano, D; Torrico, M; Yuste, J | 1 |
Kaku, T; Kato, Y; Liu, K; Liu, Q; Meng, Q; Sun, H; Wang, C | 1 |
Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
Aguilar, L; Giménez, MJ; Soriano, F | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; López, AM; Prieto, J; Sevillano, D; Torrico, M | 1 |
Cao, B; Chen, M; Chu, Y; Duan, Q; Hu, Y; Liu, Y; Sun, H; Sun, Z; Wang, H; Xu, Y; Yang, Q; Yu, Y; Zhang, R; Zhuo, C | 1 |
Aguilar, L; Alou, L; Cafini, F; García, E; Giménez, MJ; Navarro, A; Ramos-Sevillano, E; Rodríguez-Sosa, C; Sevillano, D; Yuste, J | 1 |
Deliolanis, I; Giamarellou, H; Hatzaki, D; Katsarolis, I; Lambri, N; Lebessi, E; Nikolopoulos, GK; Poulakou, G; Souli, M | 1 |
Chiba, N; Morozumi, M; Ubukata, K | 1 |
Do, HS; Jang, HS; Kwon, JJ; Lee, ES; Lee, JY; Lim, JH; Rim, JS | 1 |
Chen, H; Li, H; Wang, H; Wang, Q; Wang, Z; Zhang, F; Zhao, C | 1 |
Blasi, F; Braido, F; Di Marco, F; Santus, P; Scichilone, N | 1 |
Matsumoto, K; Mitomi, N; Sato, N; Shibasaki, S; Shitara, Y | 1 |
Abdelnour, A; Arguedas, A; Guevara, S; Soley, C; Ulloa, C | 1 |
Bachiller-Luque, P; Briongos-Figuero, LS; Carreres-Rodríguez, A; Mena-Martín, FJ; Pastor-Mancisidor, L | 1 |
Blasi, F; Concia, E; Del Prato, B; Giusti, M; Mazzei, T; Novelli, A; Polistena, B; Rossi, A; Stefani, S | 1 |
Barberán, J; Sánchez Artola, B | 1 |
Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Peng, J; Sun, H; Sun, P; Wang, C; Wang, H | 1 |
Adachi, Y; Iwata, S; Mokuno, E; Morozumi, M; Sakuma, M; Tajima, T; Ubukata, K | 1 |
Chun, J; Miura, NN; Miyabe, C; Miyabe, Y; Miyasaka, M; Miyasaka, N; Nagai, J; Nanki, T; Ohno, N; Tsuboi, R; Ueda, H | 1 |
Attanasio, V; Bernardo, M; Capoluongo, N; Carozza, A; Di Luca, M; Pallotto, C; Palmiero, G; Severino, S; Tascini, C | 1 |
Abril-Pérez, C; Botella-Estrada, R; Roca-Ginés, J; Sánchez-Arráez, J; Torres-Navarro, I | 1 |
Cabañero-Navalón, MD; García-Bustos, V; Salavert Lletí, M | 1 |
Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Llamosí, M; López-Ruiz, B; Sempere, J; Yuste, J | 1 |
Martín Guerra, JM; Moreta Rodríguez, M | 1 |
Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
Coronel, P; Domenech, M; Gimeno, M; Llamosí, M; Sempere, J; Yuste, J | 1 |
Acquasanta, A; Flammini, S; Giuliano, S; Martini, L; Sbrana, F; Tascini, C | 1 |
12 review(s) available for cephalosporin c and cefditoren
Article | Year |
---|---|
Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bacterial Infections; Cephalosporins; Chromatography, High Pressure Liquid; Half-Life; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 2001 |
Cefditoren, a new aminothiazolyl cephalosporin.
Topics: Acute Disease; Bacterial Infections; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Interactions; Humans; Maxillary Sinusitis; Pharyngitis; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2002 |
Beta-lactam antibiotics: newer formulations and newer agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Humans; Lactams; United States | 2004 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Bacterial; Europe; Humans; Latin America; Microbial Sensitivity Tests; North America; Respiratory Tract Infections; Skin Diseases, Bacterial | 2009 |
Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Penicillins; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Superinfection; Vaginitis | 2009 |
[Cefditoren and community-acquired lower respiratory tract infections (corrected)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2009 |
Cefditoren in upper and lower community-acquired respiratory tract infections.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Respiratory Tract Infections | 2011 |
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Disease Eradication; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive | 2014 |
[Cefditoren: a reality for the treatment of community infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans | 2017 |
[Role of cefditoren in the treatment of community skin and soft tissue infections: revisiting the evidence].
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Soft Tissue Infections | 2021 |
Cefditoren: a clinical overview.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Monobactams; Respiratory Tract Infections; Staphylococcus aureus | 2023 |
9 trial(s) available for cephalosporin c and cefditoren
Article | Year |
---|---|
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefadroxil; Cefuroxime; Cephalosporins; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome | 2002 |
[Clinical isolates and treatment of acute otitis media].
Topics: Acute Disease; Adolescent; Adult; Aged; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Middle Aged; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Eradication of bacteria in upper pharynx of children treated with antibiotics].
Topics: Amoxicillin; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Penicillin Resistance; Pharyngitis; Pharynx; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Topics: Acute Disease; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Prospective Studies; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections].
Topics: Adolescent; Adult; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Middle Aged; Otorhinolaryngologic Diseases; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Efficacy and safety of twice-daily administration of CTDR].
Topics: Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Patient Compliance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Urea | 2008 |
Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Diarrhea; Double-Blind Method; Half-Life; Humans; Male; Microbial Sensitivity Tests | 2007 |
In vitro Activity of Cefditoren against Middle Ear Fluid Isolates from Costa Rican Children with Otitis Media.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Costa Rica; Drug Resistance, Multiple, Bacterial; Ear, Middle; Female; Humans; Male; Microbial Sensitivity Tests; Otitis Media; Streptococcus pneumoniae | 2014 |
94 other study(ies) available for cephalosporin c and cefditoren
Article | Year |
---|---|
An in vitro characterization of cefditoren, a new oral cephalosporin.
Topics: Bacteria; beta-Lactamases; Blood Proteins; Cations; Cephalosporins; Culture Media; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Protein Binding | 1994 |
In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae; Thienamycins | 1996 |
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
Topics: Acetamides; Amino Acid Sequence; Anti-Bacterial Agents; Cephalosporins; Linezolid; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazoles; Oxazolidinones; Penicillin Resistance; Streptococcus pneumoniae; Virginiamycin | 1996 |
Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Cephalosporins; Culture Media; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Neisseria meningitidis; Streptococcus pneumoniae | 1996 |
Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
Topics: Anti-Bacterial Agents; Cephalosporins; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae.
Topics: Cephalosporins; Diffusion; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cephalosporins; Drug Resistance, Microbial; Lactams; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[In vitro activity of faropenem against beta-lactamase producing clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests | 2000 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Streptococcal Infections; Streptococcus | 2000 |
Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.
Topics: Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 2000 |
In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2000 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
[Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
Topics: Anti-Bacterial Agents; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Minocycline; Penicillin G; Penicillins; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae | 2000 |
Determination of cefditoren (ME 1206) in the plasma of elderly patients with multiple diseases using high-performance liquid chromatography.
Topics: Aged; Aged, 80 and over; Calibration; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Therapy, Combination; Equipment Design; Humans; Reference Standards; Reproducibility of Results; Respiratory Tract Infections; Sensitivity and Specificity | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Quality control parameters for cefditoren susceptibility tests.
Topics: Bacteria; Cephalosporins; Escherichia coli; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Staphylococcus aureus; Streptococcus pneumoniae | 2001 |
In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998.
Topics: Cephalosporins; Germany; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 2001 |
Oral prodrug enters cephalosporin market.
Topics: Administration, Oral; Bacterial Infections; Bronchitis; Cephalosporins; Drug Approval; Drug Interactions; Humans; Pharyngitis; Prodrugs; Skin Diseases, Bacterial; United States; United States Food and Drug Administration | 2001 |
Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.
Topics: beta-Lactamases; Cephalosporins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Prospective Studies | 2002 |
In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.
Topics: Cephalosporins; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2002 |
Cefditoren (Spectracef)--a new cephalosporin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cephalosporins; Humans; Pharyngitis | 2002 |
Activity of cefditoren against respiratory pathogens.
Topics: Cephalosporins; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2002 |
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Product Surveillance, Postmarketing; Time Factors | 2002 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Therapy for children with acute pneumococcal otitis media in an outpatient clinic].
Topics: Acute Disease; Amoxicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Humans; Infant; Middle Ear Ventilation; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Recurrence; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[High-dose cefditren therapy for children with acute otitis media that had Streptococcus pneumoniae and haemophilus influenzae isolated from the nasopharynx].
Topics: Acute Disease; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Nasopharynx; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Topics: Acute Disease; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Infant case of acute otitis media due to PISP not eradicated with double-dose of CDTR].
Topics: Cephalosporins; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media with Effusion; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome | 2001 |
[Mode of transmission and natural course of pneumococcal infection].
Topics: Age Factors; Cephalosporins; Child Day Care Centers; Community-Acquired Infections; Disease Transmission, Infectious; Humans; Infant; Nasopharynx; Penicillin Resistance; Pneumococcal Infections; Risk Factors; Streptococcus pneumoniae | 2001 |
[Study on Streptococcus pneumoniae isolated from infants in widely-separated primary care facilities in Japan].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child Day Care Centers; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Japan; Lactams; Otitis Media; Penicillin G; Serotyping; Siblings; Streptococcus pneumoniae | 2001 |
In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
Topics: Adult; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Humans; Hungary; In Vitro Techniques; Penicillin Resistance; Pneumococcal Infections; Pneumonia, Pneumococcal; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Simultaneous intravenous and intramiddle-ear dosing to determine cefditoren influx and efflux clearances in middle ear fluid in freely moving chinchillas.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Biological Transport; Cephalosporins; Chinchilla; Disease Models, Animal; Ear, Middle; Injections, Intravenous; Instillation, Drug; Male; Microdialysis; Otitis Media; Time Factors | 2003 |
Antimicrobial susceptibility of respiratory Haemophilus influenzae strains isolated from pediatric respiratory tract infections.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections | 2004 |
[Clinical effect of ceftriaxone and cefditoren administration against oral and genital gonococcal infection].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Female; Gonorrhea; Humans; Mouth Diseases; Sex Work | 2006 |
Quantification of the cephalosporin antibiotic cefditoren in human plasma by high-performance liquid chromatography.
Topics: Calibration; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Specimen Handling; Spectrophotometry, Ultraviolet; Therapeutic Equivalency | 2006 |
In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
Topics: Anti-Bacterial Agents; Asia; Cephalosporins; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory System; Staphylococcus aureus | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Penicillins; Quinolones; Streptococcus pneumoniae | 2007 |
[Relationship between protein binding and antimicrobial activities of antibiotics against Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Administration, Oral; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Haemophilus influenzae; Humans; Injections, Intravenous; Meropenem; Microbial Sensitivity Tests; Protein Binding; Streptococcus pneumoniae; Thienamycins | 2006 |
[Influence of the displacement of protein binding by ibuprofen in the activity of a third-generation cephalosporin against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding, Competitive; Blood Proteins; Cephalosporins; Drug Interactions; Drug Resistance; Humans; Ibuprofen; Microbial Sensitivity Tests; Protein Binding; Serum Albumin; Streptococcal Infections; Streptococcus pneumoniae | 2006 |
In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spain | 2007 |
In vitro activities of oral cephem and telithromycin against clinical isolates of major respiratory pathogens in Japan.
Topics: Administration, Oral; Cephalosporins; Haemophilus influenzae; Humans; Ketolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2007 |
Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefuroxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Half-Life; Kinetics; Microbial Sensitivity Tests; Phenotype | 2007 |
Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cephalosporins; Culture Media; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Protein Binding; Serum; Serum Albumin; Streptococcus pneumoniae | 2007 |
Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefuroxime; Cephalosporins; Child; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Otitis Media; Phenotype; Streptococcus pneumoniae | 2007 |
Pharmacodynamics of simulated total versus free-drug serum concentrations of a low versus a high protein bound third-generation oral cephalosporin (Cefpodoxime versus cefditoren) against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Blood Proteins; Cefpodoxime; Ceftizoxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Models, Biological; Protein Binding; Streptococcus pneumoniae | 2007 |
In vitro activity of cefditoren against clinical isolates of Escherichia coli from a Korean hospital.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Korea; Microbial Sensitivity Tests | 2007 |
influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhi
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Genes, Bacterial; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests; Peptidoglycan Glycosyltransferase; Protein Binding; Spectrophotometry, Ultraviolet | 2007 |
Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity.
Topics: Bacterial Proteins; Binding Sites; Cephalosporins; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Streptococcus pneumoniae | 2007 |
Urine bactericidal activity against Escherichia coli isolates exhibiting different resistance phenotypes/genotypes in an in vitro pharmacodynamic model simulating urine concentrations obtained after oral administration of a 400-milligram single dose of ce
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests; Models, Biological; Phenotype; Urinary Tract Infections; Urine | 2008 |
Monte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Endpoint Determination; Fasting; Humans; Male; Models, Statistical; Monte Carlo Method; Serum Bactericidal Test | 2008 |
Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: results of the Cefditoren Surveillance Study.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Europe; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 2008 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; United States | 2008 |
Efficacy of cefditoren in the treatment of upper respiratory tract infections: a pooled analysis of six clinical trials.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Treatment Outcome | 2008 |
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.
Topics: Albumins; Cephalosporins; Chemistry, Pharmaceutical; Computer Simulation; Humans; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Protein Binding; Serum; Spectrophotometry, Ultraviolet; Streptococcus pneumoniae | 2008 |
In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pneumococcal Infections; Pneumonia, Pneumococcal; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2008 |
Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2008 |
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefuroxime; Cephalosporins; Coculture Techniques; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Selection, Genetic | 2009 |
PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Caco-2 Cells; Cephalosporins; Dipeptides; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Jejunum; Kidney; Kinetics; Male; Membrane Transport Proteins; Molecular Structure; Peptide Transporter 1; Rats; Rats, Wistar; Symporters | 2009 |
Cefditoren versus community-acquired respiratory pathogens: time-kill studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2009 |
Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Automation; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Spain; Urinary Tract Infections; Young Adult | 2010 |
Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Microbial Sensitivity Tests; Species Specificity | 2010 |
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Italy; Microbial Sensitivity Tests; Respiratory Tract Infections | 2010 |
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Specificity; Cephalosporins; Disease Models, Animal; Female; HL-60 Cells; Humans; Immunization; Immunization, Passive; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Penicillin Resistance; Phagocytes; Phagocytosis; Sepsis; Serotyping; Streptococcus pneumoniae; Vaccines, Inactivated | 2010 |
Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Cephalosporins; Drug Interactions; Liver; Male; Novobiocin; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Rats, Wistar; RNA, Messenger; Verapamil | 2010 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Diffusion; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2011 |
In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Topics: Anti-Bacterial Agents; Cephalosporins; China; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.
Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Antibodies; beta-Lactams; Ceftriaxone; Cephalosporins; Complement Activation; Complement C1q; Complement C3c; Drug Resistance, Microbial; Egtazic Acid; Flow Cytometry; Humans; Immune System; Mice; Phagocytosis; Streptococcus pneumoniae | 2012 |
Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Pregnancy; Risk Factors; Treatment Outcome; Urinary Tract Infections; Young Adult | 2012 |
[Morphological changes in penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteriolysis; beta-Lactamases; Carbapenems; Cephalosporins; Child; Dose-Response Relationship, Drug; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Microscopy, Phase-Contrast; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors | 2012 |
Correlation of antibiotic prophylaxis and difficulty of extraction with postoperative inflammatory complications in the lower third molar surgery.
Topics: Adolescent; Adult; Aged; Anesthesia, Dental; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Dry Socket; Female; Humans; Male; Mandible; Middle Aged; Molar, Third; Nerve Block; Osteotomy; Pain, Postoperative; Postoperative Complications; Retrospective Studies; Surgical Flaps; Surgical Wound Infection; Tooth Extraction; Trismus; Young Adult | 2014 |
In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: a multicentre study in China.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; China; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 2014 |
Population pharmacokinetics of cefditoren pivoxil in non-infected adults.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Female; Humans; Male; Models, Biological | 2014 |
[Cerebellar syndrome induced by metronidazole: a rare side effect].
Topics: Anti-Bacterial Agents; Brain Abscess; Cefotaxime; Cephalosporins; Cerebellar Ataxia; Diagnosis, Differential; Diverticulitis; Drug Therapy, Combination; Dysarthria; Humans; Linezolid; Liver Abscess; Lung Abscess; Magnetic Resonance Angiography; Male; Metronidazole; Middle Aged; Paraneoplastic Syndromes; Vasculitis | 2016 |
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Evidence-Based Medicine; Humans; Inappropriate Prescribing; Respiratory Tract Infections | 2017 |
Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Cisplatin; Disease Models, Animal; Gene Expression Regulation; Kidney; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rats, Wistar; Renal Elimination | 2018 |
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Naphthyridines; Otitis Media; Pneumococcal Vaccines; Quinolones; Streptococcus pneumoniae; Vaccines, Conjugate | 2019 |
Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.
Topics: Animals; Cell Movement; Cephalosporins; Chemokine CXCL1; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Interleukin-8; Male; Mice; Mice, Inbred C57BL; Neutrophils; Receptors, Lysophosphatidic Acid; Signal Transduction; Vasculitis | 2019 |
Clinical efficacy of amoxicillin/clavulanate plus cefditoren as de-escalation combination therapy for endocarditis due to strongly biofilm-forming
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Humans; Length of Stay; Male; Middle Aged; Treatment Outcome | 2020 |
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome | 2020 |
A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Pneumococcal Infections; Spain; Streptococcus pneumoniae | 2022 |
Cefditoren-induced hepatitis.
Topics: Anti-Bacterial Agents; Cephalosporins; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Humans; Microbial Sensitivity Tests | 2022 |
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |
Combination of Cefditoren and
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Biofilms; Cephalosporins; COVID-19; Humans; Mice; Respiratory Tract Infections; SARS-CoV-2; Streptococcus pneumoniae | 2022 |